This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Mind of Hiroshi Miyamoto in Cancer Treatment
Introduction: Hiroshi Miyamoto, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the medical field through his innovative patent. With a focus on creating treatments for malignant tumors, his work exemplifies the intersection of science and compassion.
Latest Patents: Hiroshi Miyamoto holds a patent for an "Immunoactivation blood perfusion filter for the treatment of malignant tumors." This groundbreaking invention outlines a method for producing a natural immunologically active state in a patient by utilizing an apheresis procedure with bioincompatible biomaterials. The procedure, lasting approximately one hour, is conducted under general anesthesia for about six hours to manage the immunological shock that may occur. This method not only aids in treating malignant tumors but also addresses diseases related to immunosuppression, such as AIDS. Additionally, the patent includes the use of an apheresis column containing a blood perfusion filter with bioincompatible materials for the treatment of malignant tumors and infectious diseases.
Career Highlights: Hiroshi Miyamoto is currently associated with Otsuka Pharmaceutical Company, Limited, where he applies his expertise in innovative medical solutions. His work is pivotal in advancing therapeutic methodologies aimed at improving patient outcomes in oncology.
Collaborations: Throughout his career, Miyamoto has had the privilege of working alongside esteemed colleagues such as Yukihiko Nosé and Kazuhide Ohta. Their collaborative efforts contribute to the ongoing development of innovative treatments within the pharmaceutical industry, highlighting the importance of teamwork in research and invention.
Conclusion: Hiroshi Miyamoto's contributions to medicine through his patent for an immunoactivation blood perfusion filter showcase his commitment to enhancing cancer treatment methodologies. As a dedicated inventor, his efforts have the potential to bring hope and healing to many suffering from malignant tumors and immunosuppressive diseases. His work continues to inspire those in the fields of innovation and medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile